Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans

Autor: Carlijn Kuijk, Lotte C.A. Stiekema, Hein J. Verberne, Merijn Bos, Anne Langsted, Erik S.G. Stroes, Børge G. Nordestgaard, Sophie J. Bernelot Moens, Simone L. Verweij, Siroon Bekkering, Jeffrey Kroon, Johan G. Schnitzler, Carlijn Voermans
Přispěvatelé: Graduate School, Landsteiner Laboratory, Nuclear Medicine, ACS - Amsterdam Cardiovascular Sciences, Radiology and Nuclear Medicine, Vascular Medicine, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, AII - Inflammatory diseases, AII - Amsterdam institute for Infection and Immunity, ACS - Atherosclerosis & ischemic syndromes, ACS - Microcirculation
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Integrins
Pathology
Familial dysbetalipoproteinemia
Denmark
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
030204 cardiovascular system & hematology
Systemic inflammation
Monocytes
chemistry.chemical_compound
0302 clinical medicine
Positron Emission Tomography Computed Tomography
Hyperlipoproteinemia Type III
Leukocytosis
Cells
Cultured

Immunity
Cellular

Arteries
Middle Aged
3. Good health
Cholesterol
Phenotype
medicine.anatomical_structure
Female
medicine.symptom
Cardiology and Cardiovascular Medicine
Signal Transduction
medicine.medical_specialty
Lipoproteins
Bone Marrow Cells
Inflammation
Biology
03 medical and health sciences
All institutes and research themes of the Radboud University Medical Center
Monocytosis
Fluorodeoxyglucose F18
medicine
Humans
Triglycerides
Aged
Arteritis
Monocyte
Hematopoietic Stem Cells
medicine.disease
030104 developmental biology
chemistry
Case-Control Studies
Bone marrow
Radiopharmaceuticals
Zdroj: Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 5, pp. 969
Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 969
Arteriosclerosis, thrombosis, and vascular biology, 37(5), 969-975. Lippincott Williams and Wilkins
Arteriosclerosis, Thrombosis, and Vascular Biology
ISSN: 1079-5642
Popis: Objective— Mendelian randomization studies revealed a causal role for remnant cholesterol in cardiovascular disease. Remnant particles accumulate in the arterial wall, potentially propagating local and systemic inflammation. We evaluated the impact of remnant cholesterol on arterial wall inflammation, circulating monocytes, and bone marrow in patients with familial dysbetalipoproteinemia (FD). Approach and Results— Arterial wall inflammation and bone marrow activity were measured using 18 F-FDG PET/CT. Monocyte phenotype was assessed with flow cytometry. The correlation between remnant levels and hematopoietic activity was validated in the CGPS (Copenhagen General Population Study). We found a 1.2-fold increase of 18 F-FDG uptake in the arterial wall in patients with FD (n=17, age 60±8 years, remnant cholesterol: 3.26 [2.07–5.71]) compared with controls (n=17, age 61±8 years, remnant cholesterol 0.29 [0.27–0.40]; P P =0.001, with an increase in lipid droplets per monocyte), and a higher expression of surface integrins (CD11b, CD11c, and CD18). Patients with FD also exhibited monocytosis and leukocytosis, accompanied by a 1.2-fold increase of 18 F-FDG uptake in bone marrow. In addition, we found a strong correlation between remnant levels and leukocyte counts in the CGPS (n=103 953, P for trend 5×10–276). In vitro experiments substantiated that remnant cholesterol accumulates in human hematopoietic stem and progenitor cells coinciding with myeloid skewing. Conclusions— Patients with FD have increased arterial wall and cellular inflammation. These findings imply an important inflammatory component to the atherogenicity of remnant cholesterol, contributing to the increased cardiovascular disease risk in patients with FD.
Databáze: OpenAIRE